Camillo L, Pollastro F, Talmon M, Fresu L
Int J Mol Sci. 2025; 26(5).
PMID: 40076714
PMC: 11900946.
DOI: 10.3390/ijms26052092.
Tang C, Zhou J, Song Y, Liu S
Gastroenterol Rep (Oxf). 2025; 13:goaf019.
PMID: 40066317
PMC: 11893156.
DOI: 10.1093/gastro/goaf019.
Su F, Su M, Wei W, Wu J, Chen L, Sun X
Gut Microbes. 2025; 17(1):2476570.
PMID: 40063366
PMC: 11901428.
DOI: 10.1080/19490976.2025.2476570.
Liu F, Guo C, Liu X, Gu Z, Zou W, Tang X
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996847
PMC: 11853781.
DOI: 10.3390/cimb47020126.
Su Q, Li J, Lu Y, Liang J, Huang S, Wu M
Sci Rep. 2025; 15(1):6588.
PMID: 39994250
PMC: 11850802.
DOI: 10.1038/s41598-025-90104-1.
Macadamia oil alleviates dextran sulfate sodium-induced ulcerative colitis in mice via activating the Nrf2/Ho-1 pathway.
Shan C, Liu T, Miao F, Guo G
Food Sci Biotechnol. 2025; 34(4):1027-1036.
PMID: 39974866
PMC: 11832958.
DOI: 10.1007/s10068-024-01719-5.
Unraveling the causal association between inflammatory bowel diseases and uveitis through mendelian randomization analysis.
Zhong M, An H, Gan H
Sci Rep. 2025; 15(1):5686.
PMID: 39956872
PMC: 11830775.
DOI: 10.1038/s41598-025-90462-w.
The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology.
Aloisio Caruso E, De Nunzio V, Tutino V, Notarnicola M
Int J Mol Sci. 2025; 26(3).
PMID: 39941074
PMC: 11818434.
DOI: 10.3390/ijms26031306.
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials.
Zeng L, Liu C, Wu Y, Liu S, Zheng Y, Hao W
Stem Cell Res Ther. 2025; 16(1):65.
PMID: 39934871
PMC: 11817852.
DOI: 10.1186/s13287-025-04184-x.
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases.
Huang Q, Zhu X, Zhang Y
Biomark Res. 2025; 13(1):23.
PMID: 39901288
PMC: 11792665.
DOI: 10.1186/s40364-025-00736-8.
Mechanism underlying the role of the circRNA OMA1/miR-654-3p/RAF1 axis in children with inflammatory bowel disease.
Zhang P, Wang Z, Xu Y, Wu M
Cytotechnology. 2025; 77(2):42.
PMID: 39867828
PMC: 11759725.
DOI: 10.1007/s10616-025-00703-z.
Expression and role of CTHRC1 in inflammatory bowel disease in children.
Tang H, Gao X, Wu Z, Chen J, Chen L, Du X
Cytotechnology. 2025; 77(2):44.
PMID: 39867826
PMC: 11759733.
DOI: 10.1007/s10616-025-00705-x.
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches.
Centanni L, Cicerone C, Fanizzi F, DAmico F, Furfaro F, Zilli A
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861141
PMC: 11768140.
DOI: 10.3390/ph18010078.
Functions of METTL1/WDR4 and QKI as m7G modification - related enzymes in digestive diseases.
Zhou W, Yi Y, Cao W, Zhong X, Chen L
Front Pharmacol. 2025; 15():1491763.
PMID: 39850560
PMC: 11754259.
DOI: 10.3389/fphar.2024.1491763.
Structural equation modeling of the impact of disease activity on inflammatory bowel disease control: the mediating roles of self-efficacy and self-management behaviors.
Zhu Y, Liu K, Jiang J, Cheng X, Wang H, Long F
BMC Gastroenterol. 2025; 25(1):30.
PMID: 39844024
PMC: 11752657.
DOI: 10.1186/s12876-025-03623-6.
Akkermansia muciniphila relieves inflammatory response in DSS-induced ulcerative colitis in mice through regulating macrophage polarization via SCFAs-SLC52A2/FFAR2 pathway.
Zhang L, Wang J, Xu Y, Wei K, Lin W, Hu H
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39841217
DOI: 10.1007/s00210-025-03787-8.
Characterization of Inflammatory Bowel Disease in the Elderly According to Age of Onset.
Gonzalez M, Olmedo Martin R, Morales Bermudez A, Jimenez Perez M
J Clin Med. 2025; 13(24.
PMID: 39768503
PMC: 11728034.
DOI: 10.3390/jcm13247581.
Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization.
Su Q, Lu Y, He S, Liang J, Huang S, He Y
Sci Rep. 2025; 15(1):210.
PMID: 39747981
PMC: 11696058.
DOI: 10.1038/s41598-024-84447-4.
Liquid-liquid separation in gut immunity.
Wang Z, Zhou L, Zhong X, Jiang Y, Zhang Z, Li W
Front Immunol. 2024; 15:1505123.
PMID: 39720729
PMC: 11666445.
DOI: 10.3389/fimmu.2024.1505123.
Genetically engineered bacteria as inflammatory bowel disease therapeutics.
Zou Z, Zhang X, Zhang Q, Yin B, Zhou Y, Ye B
Eng Microbiol. 2024; 4(4):100167.
PMID: 39628589
PMC: 11611042.
DOI: 10.1016/j.engmic.2024.100167.